{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:59:30Z","timestamp":1767859170399,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,13]]},"DOI":"10.7759\/cureus.15016","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:36Z","timestamp":1620960216000},"source":"Crossref","is-referenced-by-count":1,"title":["A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients"],"prefix":"10.7759","author":[{"given":"Mandi","family":"Abdelahad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Demory Beckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson A","year":"2001","unstructured":"Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001, 345:340-50. 10.1056\/NEJM200108023450506","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000525","article-title":"Lupus and vaccinations","volume":"30","author":"Mathian A","year":"2018","unstructured":"Mathian A, Pha M, Amoura Z. Lupus and vaccinations. Curr Opin Rheumatol. 2018, 30:465-70. 10.1097\/bor.0000000000000525","journal-title":"Curr Opin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger JK","year":"2008","unstructured":"Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008, 3:499-522. 10.1146\/annurev.pathmechdis.3.121806.154316","journal-title":"Annu Rev Pathol"},{"key":"ref4","unstructured":"Influenza. (2020). Accessed. May 1, 2021: https:\/\/www.niaid.nih.gov\/diseases-conditions\/influenza."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.09.012","article-title":"Influenza vaccination in systemic lupus erythematosus: safe and protective?","volume":"6","author":"Holvast B","year":"2007","unstructured":"Holvast B, Huckriede A, Kallenberg CG, et al.. Influenza vaccination in systemic lupus erythematosus: safe and protective?. Autoimmun Rev. 2007, 6:300-5. 10.1016\/j.autrev.2006.09.012","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.30576","article-title":"Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus","volume":"63","author":"Mathian A","year":"2011","unstructured":"Mathian A, Devilliers H, Krivine A, et al.. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus. Arthritis Rheum. 2011, 63:3502-11. 10.1002\/art.30576","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna G","year":"2013","unstructured":"Fortuna G, Brennan MT. Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dent Clin North Am. 2013, 57:631-55. 10.1016\/j.cden.2013.06.003","journal-title":"Dent Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2015.0423","article-title":"The diagnosis and treatment of systemic lupus erythematosus","volume":"112","author":"Kuhn A","year":"2015","unstructured":"Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015, 112:423-32. 10.3238\/arztebl.2015.0423","journal-title":"Dtsch Arztebl Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.01.010","article-title":"Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus","volume":"47","author":"Rua-Figueroa I","year":"2017","unstructured":"Rua-Figueroa I, Lopez-Longo J, Galindo-Izquierdo M, et al.. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017, 47:38-45. 10.1016\/j.semarthrit.2017.01.010","journal-title":"Semin Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/srep37817","article-title":"Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus: a nationwide cohort study","volume":"6","author":"Chang CC","year":"2016","unstructured":"Chang CC, Chang YS, Chen WS, et al.. Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus: a nationwide cohort study. Sci Rep. 2016, 6:37817. 10.1038\/srep37817","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/17402520600800820","article-title":"Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)","volume":"13","author":"Stojanovich L","year":"2006","unstructured":"Stojanovich L. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol. 2006, 13:373-5. 10.1080\/17402520600800820","journal-title":"Clin Dev Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.081","article-title":"A\/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity","volume":"29","author":"Lu CC","year":"2011","unstructured":"Lu CC, Wang YC, Lai JH, et al.. A\/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine. 2011, 29:444-50. 10.1016\/j.vaccine.2010.10.081","journal-title":"Vaccine"},{"key":"ref13","article-title":"Safety and efficiency of influenza vaccination in systemic erythematosus patients","volume":"34","author":"Wallin L","year":"2009","unstructured":"Wallin L, Quintilio W, Locatelli F, Cassel A, Silva MB, Skare TL. Safety and efficiency of influenza vaccination in systemic erythematosus patients. Acta Reumatol Port. 2009, 34:498-502.","journal-title":"Acta Reumatol Port"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003637","article-title":"Is systemic lupus erythematosus associated with a declined immunogenicity and poor safety of influenza vaccine?: a systemic review and meta-analysis","volume":"95","author":"Huang Y","year":"2016","unstructured":"Huang Y, Wang H, Wan L, et al.. Is systemic lupus erythematosus associated with a declined immunogenicity and poor safety of influenza vaccine?: a systemic review and meta-analysis. Medicine (Baltimore). 2016, 95:3637. 10.1097\/MD.0000000000003637","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.043943","article-title":"Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease","volume":"65","author":"Holvast A","year":"2006","unstructured":"Holvast A, Huckriede A, Wilschut J, et al.. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis. 2006, 65:913-8. 10.1136\/ard.2005.043943","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147856","article-title":"Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: a meta anaylsis","volume":"11","author":"Liao Z","year":"2016","unstructured":"Liao Z, Tang H, Xu X, et al.. Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: a meta anaylsis. PLoS One. 2016, 11:e0147856. 10.1371\/journal.pone.0147856","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.057","article-title":"Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sj\u00f6gren's syndrome","volume":"31","author":"Pasoto SG","year":"2013","unstructured":"Pasoto SG, Ribeiro AC, Viana VS, et al.. Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sj\u00f6gren's syndrome. Vaccine. 2013, 31:1793-8. 10.1016\/j.vaccine.2013.01.057","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n P","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, et al.. Sj\u00f6gren syndrome. Nat Rev Dis Primers. 2016, 2:16047. 10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New treatment guidelines for Sj\u00f6gren's Disease","volume":"42","author":"Vivino FB","year":"2016","unstructured":"Vivino FB, Carsons SE, Foulks G, et al.. New treatment guidelines for Sj\u00f6gren's Disease. Rheum Dis Clin North Am. 2016, 42:531-51. 10.1016\/j.rdc.2016.03.010","journal-title":"Rheum Dis Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210509","article-title":"H1N1 vaccination in Sj\u00f6gren's syndrome triggers polyclonal B cell activation and promotes autoantibody production","volume":"76","author":"Brauner S","year":"2017","unstructured":"Brauner S, Folkersen L, Kvarnstr\u00f6m M, et al.. H1N1 vaccination in Sj\u00f6gren's syndrome triggers polyclonal B cell activation and promotes autoantibody production. Ann Rheum Dis. 2017, 76:1755-63. 10.1136\/annrheumdis-2016-210509","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.229.29","article-title":"Influenza vaccination in autoimmune rheumatic disease patients","volume":"229","author":"Milanovic M","year":"2013","unstructured":"Milanovic M, Stojanovich L, Djokovic A, et al.. Influenza vaccination in autoimmune rheumatic disease patients. Tohoku J Exp Med. 2013, 229:29-34. 10.1620\/tjem.229.29","journal-title":"Tohoku J Exp Med"},{"key":"ref22","article-title":"Pathogenesis of rheumatoid arthritis: the intersection of genetics and epigenetics","volume":"129","author":"Firestein","year":"2018","unstructured":"Firestein, GS.. Pathogenesis of rheumatoid arthritis: the intersection of genetics and epigenetics. Trans Am Clin Climatol Assoc. 2018, 129:171-82.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13322","article-title":"Clinical effectiveness of influenza vaccination in patients with rheumatoid arthritis","volume":"21","author":"Chen CM","year":"2018","unstructured":"Chen CM, Chen HJ, Chen WS, et al.. Clinical effectiveness of influenza vaccination in patients with rheumatoid arthritis. Int J Rheum Dis. 2018, 21:1246-53. 10.1111\/1756-185X.13322","journal-title":"Int J Rheum Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes IB","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365:2205-19. 10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"ref25","unstructured":"Rheumatoid arthritis. (2020). Accessed. May 1, 2021: https:\/\/www.cdc.gov\/arthritis\/basics\/rheumatoid-arthritis.html."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000877","article-title":"Efficacy and safety of hepatitis B vaccination in rheumatoid arthritis patients receiving disease-modifying antirheumatic drugs and\/or biologics therapy","volume":"25","author":"Intongkam S","year":"2019","unstructured":"Intongkam S, Samakarnthai P, Pakchotanon R, et al.. Efficacy and safety of hepatitis B vaccination in rheumatoid arthritis patients receiving disease-modifying antirheumatic drugs and\/or biologics therapy. J Clin Rheumatol. 2019, 25:329-34. 10.1097\/RHU.0000000000000877","journal-title":"J Clin Rheumatol"},{"key":"ref27","unstructured":"Patient education. disease-modifying antirheumatic drugs (DMARDs) (Beyond the Basics). (2019). Accessed: May 1, 2021: https:\/\/www.uptodate.com\/contents\/disease-modifying-antirheumatic-drugs-dmards-in-rheumatoid-arthritis-beyond-the-basics."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"Van Assen S","year":"2010","unstructured":"Van Assen S, Holvast A, Benne CA, et al.. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum. 2010, 62:75-81. 10.1002\/art.25033","journal-title":"Arthritis Rheum"},{"key":"ref29","unstructured":"General principles and overview of management of rheumatoid arthritis in adults. (2020). Accessed. May 1, 2021: https:\/\/www.uptodate.com\/contents\/general-principles-and-overview-of-management-of-rheumatoid-arthritis-in-adults."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1082-z","article-title":"Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept","volume":"17","author":"Alten R","year":"2016","unstructured":"Alten R, Bingham III CO, Cohen SB, et al.. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept. BMC Musculoskelet Disord. 2016, 17:231. 10.1186\/s12891-016-1082-z","journal-title":"BMC Musculoskelet Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.072","article-title":"The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab","volume":"29","author":"Arad U","year":"2011","unstructured":"Arad U, Tzadok S, Amir S, et al.. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine. 2011, 29:1643-8. 10.1016\/j.vaccine.2010.12.072","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic MC","year":"2007","unstructured":"Kapetanovic MC, Saxne T, Nilsson JA, et al.. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford). 2007, 46:608-11. 10.1093\/rheumatology\/kel366","journal-title":"Rheumatology (Oxford)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers","volume":"65","author":"Fomin I","year":"2006","unstructured":"Fomin I, Caspi D, Levy V, et al.. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis. 2006, 65:191-4. 10.1136\/ard.2005.036434","journal-title":"Ann Rheum Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30392-1","article-title":"Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma","volume":"3","author":"Mehta P","year":"2021","unstructured":"Mehta P, Sanchez E, Moraitis E, et al.. Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma. Lancet Rheumatol. 2021, 3:9-10. 10.1016\/S2665-9913(20)30392-1","journal-title":"Lancet Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22246","article-title":"Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"66","author":"Hua C","year":"2014","unstructured":"Hua C, Barnetche T, Combe B, et al.. Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res. 2014, 66:1016-26. 10.1002\/acr.22246","journal-title":"Arthritis Care Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.58","article-title":"An evidence-based systematic review on medical therapies for inflammatory bowel disease","volume":"106","author":"Talley NJ","year":"2011","unstructured":"Talley NJ, Abreu MT, Achkar JP, et al.. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011, 106:S2-25. 10.1038\/ajg.2011.58","journal-title":"Am J Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang YZ","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014, 20:91-9. 10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury M","year":"2014","unstructured":"Fakhoury M, Negrulj R, Mooranian A, et al.. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014, 7:113-20. 10.2147\/JIR.S65979","journal-title":"J Inflamm Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-015-1042-7","article-title":"Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial","volume":"50","author":"Matsumoto H","year":"2015","unstructured":"Matsumoto H, Ohfuji S, Watanabe K, et al.. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial. J Gastroenterol. 2015, 50:876-86. 10.1007\/s00535-015-1042-7","journal-title":"J Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv152","article-title":"Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and\/or biologics: a two-year prospective study","volume":"9","author":"Launay O","year":"2015","unstructured":"Launay O, Abitbol V, Krivine A, et al.. Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and\/or biologics: a two-year prospective study. J Crohns Colitis. 2015, 9:1096-107. 10.1093\/ecco-jcc\/jjv152","journal-title":"J Crohns Colitis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"DeBruyn J","year":"2016","unstructured":"DeBruyn J, Fonseca K, Ghosh S, et al.. Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial. Inflamm Bowel Dis. 2016, 22:638-47. 10.1097\/MIB.0000000000000615","journal-title":"Inflamm Bowel Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200912002-00105","article-title":"Influenza and pneumococcal immunization in inflammatory bowel disease patients","volume":"15","author":"Okoji O","year":"2009","unstructured":"Okoji O, Nguyen H, Borum M. Influenza and pneumococcal immunization in inflammatory bowel disease patients. Inflamm Bowel Dis. 2009, 15:S35-6. 10.1097\/00054725-200912002-00105","journal-title":"Inflamm Bowel Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx101","article-title":"Immunogenicity of quadrivalent influenza vaccine for patients with inflammatory bowel disease undergoing immunosuppressive therapy","volume":"24","author":"Shirai S","year":"2018","unstructured":"Shirai S, Hara M, Sakata Y, et al.. Immunogenicity of quadrivalent influenza vaccine for patients with inflammatory bowel disease undergoing immunosuppressive therapy. Inflamm Bowel Dis. 2018, 24:1082-91. 10.1093\/ibd\/izx101","journal-title":"Inflamm Bowel Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200912002-00008","article-title":"Immunogenicity of influenza vaccination in children with inflammatory bowel disease","volume":"15","author":"DeBruyn J","year":"2009","unstructured":"DeBruyn J, Hilsden R, Wrobel I. Immunogenicity of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis. 2009, 15:S3. 10.1097\/00054725-200912002-00008","journal-title":"Inflamm Bowel Dis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen G","year":"2012","unstructured":"Cullen G, Bader C, Korzenik JR, et al.. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut. 2012, 61:385-91. 10.1136\/gutjnl-2011-300256","journal-title":"Gut"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu Y","year":"2009","unstructured":"Lu Y, Jacobson DL, Ashworth LA, et al.. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009, 104:444-53. 10.1038\/ajg.2008.120","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/58842-a-review-of-the-efficacy-of-influenza-vaccination-in-autoimmune-disease-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:56Z","timestamp":1707506936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/58842-a-review-of-the-efficacy-of-influenza-vaccination-in-autoimmune-disease-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.15016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,13]]}}}